Greenwich LifeSciences, Inc.
GLSI· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2020 | Q2 2019 |
|---|---|---|
| Net Income | -$210.43K | -$2.60M |
| EPS Diluted | -$0.02 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Greenwich LifeSciences, Inc. · CIK 1799788 · Engraved from SEC EDGAR